128 related articles for article (PubMed ID: 38193647)
1. Chronic high level parasitemia in HIV-infected individuals with or without visceral leishmaniasis in an endemic area in North-West Ethiopia: potential superspreaders?
van Griensven J; van Henten S; Kibret A; Kassa M; Beyene H; Abdellati S; de Hondt A; Adriaensen W; Vogt F; Pareyn M; Ritmeijer K; Diro E
Clin Infect Dis; 2024 Jan; ():. PubMed ID: 38193647
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study.
van Griensven J; van Henten S; Mengesha B; Kassa M; Adem E; Endris Seid M; Abdellati S; Asefa W; Simegn T; Debasu D; Bogale T; Gedamu Y; Van Den Bossche D; Adriaensen W; Van der Auwera G; Cnops L; Vogt F; Diro E
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007765. PubMed ID: 31593563
[TBL] [Abstract][Full Text] [Related]
3. Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context.
Molina R; Jiménez M; García-Martínez J; San Martín JV; Carrillo E; Sánchez C; Moreno J; Alves F; Alvar J
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008253. PubMed ID: 32324738
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.
Guedes DL; Silva EDD; Castro MCAB; Júnior WLB; Ibarra-Meneses AV; Tsoumanis A; Adriaensen W; van Griensven J; Pereira VRA; Medeiros ZM
PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010542. PubMed ID: 35714136
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients.
Adriaensen W; Abdellati S; van Henten S; Gedamu Y; Diro E; Vogt F; Mengesha B; Adem E; Kestens L; van Griensven J
Front Cell Infect Microbiol; 2018; 8():428. PubMed ID: 30619775
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.
Guedes DL; Justo AM; Barbosa Júnior WL; Silva EDD; Aquino SR; Lima Junior MSDC; Montarroyos U; Bezerra GSN; Vieira AVB; Pereira VRA; Medeiros ZM
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009067. PubMed ID: 33476331
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive microbiopsies: a novel sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani.
Kirstein OD; Abbasi I; Horwitz BZ; Skrip L; Hailu A; Jaffe C; Li LL; Prow TW; Warburg A
Int J Parasitol; 2017 Sep; 47(10-11):609-616. PubMed ID: 28455239
[TBL] [Abstract][Full Text] [Related]
8. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
[TBL] [Abstract][Full Text] [Related]
9. Detection of asymptomatic Leishmania infection in blood donors at two blood banks in Ethiopia.
Mohammed R; Melkamu R; Pareyn M; Abdellati S; Bogale T; Engidaw A; Kinfu A; Girma T; van Griensven J
PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011142. PubMed ID: 36893183
[TBL] [Abstract][Full Text] [Related]
10. Visceral Leishmaniasis-Human Immunodeficiency Virus-Coinfected Patients Are Highly Infectious to Sandflies in an Endemic Area in India.
Singh OP; Chaubey R; Kushwaha AK; Fay MP; Sacks D; Sundar S
J Infect Dis; 2024 Jun; 229(6):1909-1912. PubMed ID: 38713583
[TBL] [Abstract][Full Text] [Related]
11. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.
Singh OP; Tiwary P; Kushwaha AK; Singh SK; Singh DK; Lawyer P; Rowton E; Chaubey R; Singh AK; Rai TK; Fay MP; Chakravarty J; Sacks D; Sundar S
Lancet Microbe; 2021 Jan; 2(1):e23-e31. PubMed ID: 33615281
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, India.
Mahajan R; Owen SI; Kumar S; Pandey K; Kazmi S; Kumar V; Adams ER; Harshana A; Burza S
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010718. PubMed ID: 36040931
[TBL] [Abstract][Full Text] [Related]
13.
van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
[No Abstract] [Full Text] [Related]
14. High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.
Rezaei Z; Sarkari B; Dehghani M; Layegh Gigloo A; Afrashteh M
Parasitol Res; 2018 Aug; 117(8):2591-2595. PubMed ID: 29860572
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of PCR procedures for detecting and quantifying Leishmania donovani DNA in large numbers of dried human blood samples from a visceral leishmaniasis focus in Northern Ethiopia.
Abbasi I; Aramin S; Hailu A; Shiferaw W; Kassahun A; Belay S; Jaffe C; Warburg A
BMC Infect Dis; 2013 Mar; 13():153. PubMed ID: 23530965
[TBL] [Abstract][Full Text] [Related]
16. Leishmania and HIV co-infection: first naturally Leishmania strain presenting decreased susceptibility to miltefosine, recovered from a patient in Portugal.
Pinto AI; Caldas C; Santarém N; Luelmo S; Costa I; Martins C; Monteiro R; Conde S; Tavares R; da Silva AC
J Infect Public Health; 2024 May; 17(5):810-818. PubMed ID: 38522155
[TBL] [Abstract][Full Text] [Related]
17. The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
Abongomera C; Diro E; Vogt F; Tsoumanis A; Mekonnen Z; Admassu H; Colebunders R; Mohammed R; Ritmeijer K; van Griensven J
Clin Infect Dis; 2017 Oct; 65(10):1703-1710. PubMed ID: 29020196
[TBL] [Abstract][Full Text] [Related]
18. A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?
van Griensven J; Diro E; Lopez-Velez R; Ritmeijer K; Boelaert M; Zijlstra EE; Hailu A; Lynen L
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3011. PubMed ID: 25101627
[TBL] [Abstract][Full Text] [Related]
19. Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts.
Kubar J; Marty P; Lelièvre A; Quaranta JF; Staccini P; Caroli-Bosc C; Le Fichoux Y
AIDS; 1998 Nov; 12(16):2147-53. PubMed ID: 9833855
[TBL] [Abstract][Full Text] [Related]
20. Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.
Cota GF; de Sousa MR; Rabello A
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1153. PubMed ID: 21666786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
